Véronique Loustaud-Ratti, Paul Carrier, Chanlina Vong and Marie Essig Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir Hepatology 59
Article first published online: 14 APR 2014 | DOI: 10.1002/hep.26730
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.